The September 2008 issue of the European Journal of Heart Failure includes a state of the art paper on the use of natriuretic peptide levels in clinical practice.
The issue also includes a short review on the role of correction of anaemia in patients with heart failure.
A paper from Italy reports the first results of a pilot study to assess the safety and feasibility of a new device for long term vagal stimulation for treating patients with advanced heart failure.
Two trial design papers are published this month. The HEAAL study aims to establish an optimal dosing regime for losartan in patients with symptomatic heart failure who are intolerant of angiotensin converting enzyme inhibitors. The DOT-HF study is designed to evaluate whether ambulatory monitoring of intrathoracic impedance can improve outcome in heart failure patients with cardiac resynchronisation therapy or an implantable defibrillator.
Finally, this issue also includes reports from two studies of heart disease in pregnancy.
Table of contents for the September issue available here
Access this journal online